Quantum Discovery Labs » MRDD http://q-pharm.com The drug discovery company Fri, 02 Mar 2012 06:38:21 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 Do we need those nM-inhibitors? http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/ http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/#comments Wed, 11 Nov 2009 13:46:28 +0000 Peter Fedichev, Quantum CTO http://q-pharm.com/?p=122
  • Does size matter?
  • Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?
    • ]]>     http://q-pharm.com/2009/11/do-we-need-those-nm-inhibitors/feed/ 1     LD50 vs. MRDD: what’s death for a mice is good enough for a man http://q-pharm.com/2008/01/ld50-vs-mrdd-whats-death-for-a-mice-is-good-enough-for-a-man/ http://q-pharm.com/2008/01/ld50-vs-mrdd-whats-death-for-a-mice-is-good-enough-for-a-man/#comments Thu, 24 Jan 2008 20:00:00 +0000 fedichev http://q-pharm.com/?p=24
  • Toxicity Prediction
  • Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness?
  • How good are biological data – II: Trombine, GSK, GPCR
  • Do we need those nM-inhibitors?
  • How good are biological experiments? HERG binding data analysis
    • ]]>     http://q-pharm.com/2008/01/ld50-vs-mrdd-whats-death-for-a-mice-is-good-enough-for-a-man/feed/ 0     Drug likeness: what do bioavailability and toxicity properties tell us about druglikeness? http://q-pharm.com/2008/01/drug-likeness-what-do-bioavailability-and-toxicity-properties-tell-us-about-druglikeness/ http://q-pharm.com/2008/01/drug-likeness-what-do-bioavailability-and-toxicity-properties-tell-us-about-druglikeness/#comments Wed, 09 Jan 2008 10:37:00 +0000 fedichev http://q-pharm.com/?p=21
  • Toxicity Prediction
  • Does size matter?
  • How drug-like are vendor libraries?
  • Do we need those nM-inhibitors?
  • LD50 vs. MRDD: what’s death for a mice is good enough for a man
    • ]]>     http://q-pharm.com/2008/01/drug-likeness-what-do-bioavailability-and-toxicity-properties-tell-us-about-druglikeness/feed/ 0